Effects of PCSK9 inhibitor evolocumab on preventing early neurological deterioration in acute ischemic stroke patients with or without large artery atherosclerosis: a subgroup analysis of a randomized trial
Authors
Xidan Li (ORCID: https://orcid.org/0000-0001-9229-1236)
Hua Cao
Jing Liu (ORCID: https://orcid.org/0000-0002-0493-296X)
Jiahui Liu (ORCID: https://orcid.org/0000-0001-6496-435X)
Ying Li (ORCID: https://orcid.org/0000-0002-0882-5926)
Liyuan Cheng
Xiaofei Ji (ORCID: https://orcid.org/0000-0002-6104-1952)
Wen Tian
Institutions
Dalian Medical University (CN)
Dalian University of Technology (CN)
First Affiliated Hospital of Dalian Medical University (CN)
Effects of PCSK9 inhibitor evolocumab on preventing early neurological deterioration in acute ischemic stroke patients with or without large artery atherosclerosis: a subgroup analysis of a randomized trial
Xidan Li, Hua Cao, Jing Liu, Jiahui Liu et al.
Journal
BMC Neurology
Topics
Lipoproteins and Cardiovascular Health
article
Effects of PCSK9 inhibitor evolocumab on preventing early neurological deterioration in acute ischemic stroke patients with or without large artery atherosclerosis: a subgroup analysis of a randomized trial
Dalian Medical University (CN), Dalian University of Technology (CN), First Affiliated Hospital of Dalian Medical University (CN), Zhejiang University (CN)